Skip to main content
. 2019 Oct 17;2019:3679493. doi: 10.1155/2019/3679493

Table 2.

Bivariate analysis using categorical testosterone levels within the PCOS cohort.

High testosterone (n = 38) Normal testosterone (n = 36) p value N
Mean ± SD age (range) 32.4 ± 8.2 (14.9–57.0) 39.7 ± 13.8 (13.63–73.69) 0.008 74
Mean ± SD kg/m2 BMI (range) 34.3 ± 7.0 (21.0–54.5) 27.9 ± 6.3 (17.93–48.79) <0.001 74
Mean ± SD 24 hr urine panel (range)
 Calcium (mg/day) 223.7 ± 158.5 (35.5–913.6) 198.3 ± 87.7 (50.5–366.7) 0.426 65
 Citrate (mg/day) 709.6 ± 411.7 (118–1903) 517.1 ± 257.9 (82–956 0.041 54
 Creatinine (g/day) 1.3 ± 0.5 (0.6–3.2) 1.2 ± 0.3 (0.6–1.6) 0.224 56
 Oxalate (mg/day) 37.6 ± 12.3 (17–66) 39.3 ± 18.3 (19–113) 0.681 58
 Sodium (mmol/day) 144.4 ± 54.1 (49–282) 123.8 ± 47.8 (52–283) 0.154 52
 Uric acid (mg/day) 565.3 ± 225.2 (179–1016) 461.4 ± 126.9 (208–739) 0.028 60
 Volume (ml/day) 1721.8 ± 822.9 (581–3440) 1561.1 ± 769.6 (590–3259) 0.466 53
No. abnormality (%)
 Hypercalciuria (>200 mg/day) 17 (51.5%) 18 (56.3%) 0.893 65
 Hypocitraturia (<550 mg/day) 11 (36.7%) 13 (54.2%) 0.312 54
 Hyperoxaluria (>40 mg/day) 13 (41.9%) 7 (25.9%) 0.316 58
 Hypernatriuria (>150 mmol/day) 12 (40.0%) 3 (13.6%) 0.078 52
 Hyperuricosuria (>750 mg/day) 8 (23.5%) 0 (0%) 0.008 60
 Low volume (<2000 ml/day) 17 (63.0%) 18 (69.2%) 0.848 53
Mean ± SD stone composition % (range)
 CaOMH 35.7 ± 31.8 (0–80) 59.0 ± 26.0 (0–90) 0.062 24
 CaODH 16.4 ± 17.8 (0–60) 17.5 ± 21.5 (0–50) 0.899 24
 CaPh 31.4 ± 31.8 (0–90) 16.5 ± 23.3 (0–80) 0.199 24
 CaHPh 7.9 ± 22.3 (0–80) 0.209 24
 MAP 4.3 ± 16.0 (0–60) 0.336 24
 UA 0.7 ± 2.7 (0–10) 3.0 ± 6.8 (0–20) 0.332 24
No. greater than 70% mixed (%) 7 (50%) 4 (40%) 1.000 24

No adjustments made for confounding variables, original analysis only, and therefore, p values not referenced in discussion. Stones qualified as pure if the dominant component made up ≥70% of the stone.